Queen Square Analytics (QSA) and University College London (UCL) formally announce their partnership collaborating on advances in neurological imaging processing services and technology. QSA was formed as a spin-out from UCL’s Queen Square MS clinical trials office and Centre for Medical Image Computing with considerable support from UCL’s commercialisation company, UCL Business Ltd (UCLB).
As a part of the shareholding and partnership, the QSA Board of Directors is joined by UCLB Senior Business Manager, Dr Weng Sie Wong who commented:
“The launch of QSA as a UCL spin-out is testament to the effort the team has put into creating a commercial entity that can work within the pharmaceutical sector, as well as applying technology that can have life-changing benefits to those that live with multiple sclerosis. I am delighted to be able to continue supporting the QSA team on its spin-out journey.”
The formal announcement from UCL can be found here - "Queen Square Analytics launch: developing breakthrough imaging analysis technology for trials".
Comments